COSM News & Events

Stock indexes retreated amid losses for the heavyweight chip sector, making the Nasdaq the laggard, while the Dow pulled back from a record high reached in morning trading. Memory producers sank even though Samsung posted a 19-fold surge in profit last quarter. The surge was in line with the sector's rally this year, but markets appear to be growing increasingly skeptical on whether AI hyperscalers can justify elevated levels of capital expenditure on infrastructure. Yields edged higher after attacks on an LNG tanker in the Middle East tempered hopes of lower energy inflation.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists. v1. STOCK NEWS:Walmartsaid it would cut prices on many summer staplesfrom President Trump saying the retail giant was doing so at his requestChina's DeepSeek is developing its own AI chip in a push to reduce reliance on Nvidiaand Huawei chips,Vertex Pharmaceuticalsto acquire Crinetics Pharmaceuticalsfor $85 per share in cash, for a total equity value of approximately $10BSamsung Electronicsreported, but the AI-fueled earnings still failed to meet high investor expectationsMetadebuted its, saying it will help power image generation in Meta Advantage+ creative "in the coming weeks"2. WALL STREET CALLS:Wall Streetof SpaceX, including Raymond James starting the stock with a Strong Buy rating and $800 price targetScotiabankCloudflareto OutperformBofAAdobeat Underperform with a $190 price target, down from the Buy rating the firm previously heldDeutsche BankFirst Solarto BuyMelius ResearchAmerican Airlinesto Hold3. AROUND THE WEB:Big banks have held talks in recent months to buy a card network owned by Fiserv, Reuters and WSJ reportMicrosoftwill replace OpenAI and Anthropic with its own AI in some apps, Bloomberg saysMetasaid four states are seeking $1.4T in penalties over accusations it designed its social media platforms to addict young users and misled the public on their safety, Reuters reportsAmazonis seeking to raise at least $25B through a U.S. dollar bond sale to fund investments in artificial intelligence infrastructure, Bloomberg reportsPresident Trump is expected to support a potential sale of Lockheed Martin'sF-35 Lightning II jets to Turkey during a visit to Ankara, Reuters says4. MOVERS:Digital Oceangained afterit expects Q2 RPO to exceed $800MRedwood Trustwas higher after highlightingFigmaincreased after BofAcoverage with a Buy ratingRivianwas lower after75M shares of stockUnited States Antimonyfell after announcing the5. EARNINGS/GUIDANCE:Interactive Strengthraised itsCosmos HealthreportedShellissued anAbbVieprovided itsand cut its guidance for FY26Sealsqreportedand backed its guidance for FY26INDEXES:The Dow fell 130.76, or 0.25%, to 52,925.15, the Nasdaq lost 302.47, or 1.16%, to 25,818.69, and the S&P 500 declined 33.58, or 0.45%, to 7,503.85.

Cosmos Health announced that it has repurchased an additional 230,000 shares of its common stock in the open market at an average price of approximately 25.39c per share. The company has now repurchased a total of 3.87M shares for approximately $758,000 under its previously announced share repurchase program of up to $5M. Greg Siokas, CEO of Cosmos Health, stated: "We are continuing to repurchase our shares with discipline and conviction, reflecting our belief that the market continues to undervalue the strength of our platform and the trajectory of our business."

The company said, "Based on preliminary results, the Company expects to report second-quarter 2026 revenue of approximately $19.4 million, up approximately 31.5% from $14.75 million in Q2 2025, and first-half revenue of approximately $37.3 million, up approximately 31% from $28.46 million in H1 2025 - both the highest in the Company's history. Full financial results and commentary will be provided in the Company's Q2 2026 earnings release."

Cosmos Health announced that it has repurchased an additional 220,000 shares of its common stock in the open market at an average price of approximately 22.29c per share, continuing the buyback activity carried out under its ongoing repurchase program. The company has now repurchased a total of 3.64M shares for approximately $700,000 under its previously announced share repurchase program of up to $5M, it noted. The company intends to continue making open market purchases, subject to market conditions, under the program, which expires on December 31, 2026, and may be renewed at the company's sole discretion, Cosmos Health stated.